Literature DB >> 9581587

D-lactic acidosis: pathologic consequence of saprophytism.

A Vella1, G Farrugia.   

Abstract

In this report, we describe a 50-year-old woman with a short bowel who had recurrent episodes of weakness, ataxia, slurred speech, confusion, and nausea. D-Lactic acidosis was diagnosed on the basis of a D-lactate level of 8.2 mmol/L (normal, 0 to 0.25) obtained during an episode of confusion. D-Lactic acidosis is a potentially fatal clinical condition seen in patients with a short small intestine and an intact colon. Excessive production of D-lactate by abnormal bowel flora overwhelms normal metabolism of D-lactate and leads to an accumulation of this enantiomer in the blood. This disorder provides insight into the role of intestinal flora in human metabolism and demonstrates the manner in which altered intestinal flora can produce disease in humans. Increased awareness of D-lactic acidosis is necessary for prompt and appropriate treatment. The pathophysiology and treatment of D-lactic acidosis are reviewed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581587     DOI: 10.1016/S0025-6196(11)63729-4

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  13 in total

1.  Effects of yeast products on the intestinal morphology, barrier function, cytokine expression, and antioxidant system of weaned piglets.

Authors:  Huan-Sheng Yang; Fei Wu; Li-Na Long; Tie-Jun Li; Xia Xiong; Peng Liao; Hong-Nan Liu; Yu-Long Yin
Journal:  J Zhejiang Univ Sci B       Date:  2016 Oct.       Impact factor: 3.066

2.  Utilization of D-Lactate as an Energy Source Supports the Growth of Gluconobacter oxydans.

Authors:  Binbin Sheng; Jing Xu; Yingxin Zhang; Tianyi Jiang; Sisi Deng; Jian Kong; Chao Gao; Cuiqing Ma; Ping Xu
Journal:  Appl Environ Microbiol       Date:  2015-04-10       Impact factor: 4.792

3.  Effects of lactadherin on plasma D-lactic acid and small intestinal MUC2 and claudin-1 expression levels in rats with rotavirus-induced diarrhea.

Authors:  Rui Xu; Yi-Hui Lei; Jun Shi; Yi-Jun Zhou; Ying-Wei Chen; Zhen-Juan He
Journal:  Exp Ther Med       Date:  2016-01-22       Impact factor: 2.447

4.  Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product.

Authors:  Sylvia H Duncan; Petra Louis; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

5.  Quinone-dependent D-lactate dehydrogenase Dld (Cg1027) is essential for growth of Corynebacterium glutamicum on D-lactate.

Authors:  Osamu Kato; Jung-Won Youn; K Corinna Stansen; Daisuke Matsui; Tadao Oikawa; Volker F Wendisch
Journal:  BMC Microbiol       Date:  2010-12-15       Impact factor: 3.605

Review 6.  D-lactic acidosis: an underrecognized complication of short bowel syndrome.

Authors:  N Gurukripa Kowlgi; Lovely Chhabra
Journal:  Gastroenterol Res Pract       Date:  2015-04-22       Impact factor: 2.260

Review 7.  Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review.

Authors:  Amy Wallis; Michelle Ball; Sandra McKechnie; Henry Butt; Donald P Lewis; Dorothy Bruck
Journal:  J Transl Med       Date:  2017-06-07       Impact factor: 5.531

8.  Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data.

Authors:  Sabina Więcek; Jerzy Chudek; Halina Woś; Maria Bożentowicz-Wikarek; Bożena Kordys-Darmolinska; Urszula Grzybowska-Chlebowczyk
Journal:  Dis Markers       Date:  2018-07-12       Impact factor: 3.434

9.  Kynurenine Pathway Pathologies: do Nicotinamide and Other Pathway Co-Factors have a Therapeutic Role in Reduction of Symptom Severity, Including Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).

Authors:  Adele Blankfield
Journal:  Int J Tryptophan Res       Date:  2013-07-21

Review 10.  What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism?

Authors:  Jing Ma; Adrian Vella
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.